CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Quinagolide hydrochloride

Last Updated: November 23, 2005
Result type: Reports
Project Number: SR0046-000
Product Line: Reimbursement Review

Generic Name: Quinagolide hydrochloride

Brand Name: Norprolac

Manufacturer: Ferring Pharmaceuticals

Therapeutic Area: Hyperprolactinemia

Indications: Hyperprolactinemia

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: May 17, 2006

Recommendation Type: List with clinical criteria and/or conditions